Treatment of severe peri-implant bone loss using autogenous bone and a bioabsorbable polymer that delivered doxycycline (Atridox).
With an increase of the number of implants being inserted, it is inevitable that the number of cases of peri-implantitis with loss of bone will rise. We report a case in which an autogenous cancellous bone graft was placed into the peri-implant bone defect and given protection with a bioabsorbable polymer barrier (Atridox) that released doxycycline slowly.
Büchter
André
A
Department of Cranio-Maxillofacial Surgery, University of Münster, Waldeyerstrasse 30, D-48129 Münster, Germany. Buchtea@uni-muenster.de
Kleinheinz
Johannes
J
Meyer
Ulrich
U
Joos
Ulrich
U
D020341:Absorbable Implants; D000368:Aged; D016301:Alveolar Bone Loss / Q000188:drug therapy* / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002710:Chlorhexidine / Q000627:therapeutic use; D004318:Doxycycline / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009067:Mouthwashes / Q000627:therapeutic use; D014182:Transplantation, Autologous / Q000379:methods
D000900:Anti-Bacterial Agents; D009067:Mouthwashes; D004318:Doxycycline; D002710:Chlorhexidine